Stay updated on ACTT: Remdesivir for Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.

Latest updates to the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page
- Check7 days agoChange DetectedThe bottom notice about government funding/operating status was removed. The page no longer displays information about potential delays or where to check operating status.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe Locations section now lists updated study sites across multiple countries, with some sites added and others removed. This changes where the trial is recruiting and how to reach the appropriate site for enrollment.SummaryDifference0.2%

- Check50 days agoChange DetectedUpdate includes a new operating status notice and version bump to v3.2.0; removal of the previous v3.1.0 note indicates version update.SummaryDifference1%

- Check58 days agoChange DetectedUpdated page version from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.0%

- Check65 days agoChange DetectedCore content on drug safety and related topics has been removed, reducing important information about drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs.SummaryDifference0.1%

- Check73 days agoChange DetectedUpdated to revision v3.0.2, replacing v3.0.1; the Back to Top link was removed. No substantive changes to core content like pricing or availability are indicated.SummaryDifference0.1%

Stay in the know with updates to ACTT: Remdesivir for Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.